Total Payments
$5,227
2024 Payments
$449.89
Companies
50
Transactions
256
Medicare Patients
951
Medicare Billing
$64,040
Payment Breakdown by Category
Food & Beverage$4,542 (86.9%)
Education$684.74 (13.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,542 | 243 | 86.9% |
| Education | $684.74 | 13 | 13.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $438.13 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $389.47 | 30 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $281.86 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $251.19 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $249.22 | 11 | $0 (2024) |
| Celgene Corporation | $247.01 | 12 | $0 (2023) |
| Incyte Corporation | $213.57 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $210.79 | 3 | $0 (2018) |
| Genentech USA, Inc. | $192.83 | 9 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $189.73 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.89 | 12 | Heron Therapeutics, Inc. ($121.85) |
| 2023 | $318.28 | 15 | Novartis Pharmaceuticals Corporation ($72.45) |
| 2022 | $68.71 | 3 | Puma Biotechnology, Inc. ($27.22) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $830.02 | 38 | Incyte Corporation ($166.64) |
| 2018 | $1,356 | 69 | E.R. Squibb & Sons, L.L.C. ($160.55) |
| 2017 | $2,192 | 118 | Amgen Inc. ($260.18) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Heron Therapeutics, Inc. | APONVIE (Drug), ZYNRELEF | Food and Beverage | Cash or cash equivalent | $121.85 | General |
| Category: NAUSEAVOMITING | ||||||
| 08/06/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $26.92 | General |
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.92 | General |
| 05/23/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 03/28/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $24.29 | General |
| 03/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 02/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Oncology | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI, MONJUVI | Food and Beverage | Cash or cash equivalent | $20.92 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 08/30/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2023 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 08/03/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 07/20/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $16.96 | General |
| 07/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 07/06/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Oncology | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Oncology | ||||||
| 06/07/2023 | Amgen Inc. | Nplate (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Hematology | ||||||
| 05/25/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: Hematology/Oncology | ||||||
| 05/22/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 271 | 311 | $91,624 | $16,523 |
| 2022 | 1 | 189 | 247 | $64,615 | $11,455 |
| 2021 | 2 | 253 | 279 | $73,044 | $16,513 |
| 2020 | 1 | 238 | 320 | $83,520 | $19,550 |
Total Patients
951
Total Services
1,157
Medicare Billing
$64,040
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 192 | 229 | $59,906 | $10,541 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 82 | $31,718 | $5,982 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 189 | 247 | $64,615 | $11,455 | 17.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 151 | 166 | $43,426 | $8,552 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 102 | 113 | $29,619 | $7,960 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 238 | 320 | $83,520 | $19,550 | 23.4% |
About Dr. Unknown Cherry, MD
Dr. Unknown Cherry, MD is a Hematology & Oncology healthcare provider based in Coos Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689659377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Unknown Cherry, MD has received a total of $5,227 in payments from pharmaceutical and medical device companies, with $449.89 received in 2024. These payments were reported across 256 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($4,542).
As a Medicare-enrolled provider, Cherry has provided services to 951 Medicare beneficiaries, totaling 1,157 services with total Medicare billing of $64,040. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Coos Bay, OR
- Active Since 12/14/2005
- Last Updated 05/20/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689659377
Products in Payments
- OPDIVO (Biological) $219.95
- Kyprolis (Biological) $182.16
- JEVTANA (Drug) $173.98
- Revlimid (Drug) $147.79
- FOUNDATIONONE (Device) $144.37
- XTANDI (Drug) $139.56
- Neulasta (Biological) $123.49
- APONVIE (Drug) $121.85
- VELCADE (Drug) $110.25
- AKYNZEO (Drug) $108.86
- ADCETRIS (Biological) $103.46
- TECENTRIQ (Biological) $100.95
- JAKAFI (Drug) $99.66
- ZALTRAP (Drug) $99.00
- Rubraca (Drug) $96.95
- KEYTRUDA (Biological) $96.56
- IRESSA (Drug) $91.56
- RYBREVANT (Drug) $89.99
- Imbruvica (Drug) $80.58
- JADENU (Drug) $72.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.